Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy P Cripe

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Plos One|January 22, 2009
Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virusYonatan Y Mahller, Jon P Williams, William H Baird, et al.
Heliyon|January 2, 2023
An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumorsMohamed S Abdelbaki, Mariko Dawn DeWire Schottmiller, Timothy P Cripe, et al.
The Lancet. Respiratory Medicine|April 1, 2022
Cardiorespiratory management of Duchenne muscular dystrophy: emerging therapies, neuromuscular genetics, and new clinical challengesDavid J Birnkrant, Luca Bello, Russell J Butterfield, et al.
Plos One|May 19, 2011
Cancer screening by systemic administration of a gene delivery vector encoding tumor-selective secretable biomarker expressionAndrew W Browne, Jennifer L Leddon, Mark A Currier, et al.
Viruses|March 16, 2018
High Mobility Group Box 1 Influences HSV1716 Spread and Acts as an Adjuvant to ChemotherapyLeslee Sprague, Joel M Lee, Brian J Hutzen, et al.
Cancer Research|June 3, 2006
Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase AJeffrey A Toretsky, Verda Erkizan, Amy Levenson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2008
Efficacy and safety of the oncolytic herpes simplex virus rRp450 alone and combined with cyclophosphamideMark A Currier, Rebecca A Gillespie, Nancy M Sawtell, et al.
Pediatric Blood & Cancer|October 14, 2014
Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children's Oncology GroupMichael J Burke, Charlotte Ahern, Brenda J Weigel, et al.
Cancer Research|August 25, 2012
In vivo regulation of TGF-β by R-Ras2 revealed through loss of the RasGAP protein NF1Deanna M Patmore, Sara Welch, Patricia C Fulkerson, et al.
Frontiers in Immunology|June 19, 2024
Enhanced IL-12 transgene expression improves oncolytic viroimmunotherapyYeaseul Kim, Uksha Saini, Doyeon Kim, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Plos One|January 22, 2009
Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virusYonatan Y Mahller, Jon P Williams, William H Baird, et al.
Heliyon|January 2, 2023
An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumorsMohamed S Abdelbaki, Mariko Dawn DeWire Schottmiller, Timothy P Cripe, et al.
The Lancet. Respiratory Medicine|April 1, 2022
Cardiorespiratory management of Duchenne muscular dystrophy: emerging therapies, neuromuscular genetics, and new clinical challengesDavid J Birnkrant, Luca Bello, Russell J Butterfield, et al.
Plos One|May 19, 2011
Cancer screening by systemic administration of a gene delivery vector encoding tumor-selective secretable biomarker expressionAndrew W Browne, Jennifer L Leddon, Mark A Currier, et al.
Viruses|March 16, 2018
High Mobility Group Box 1 Influences HSV1716 Spread and Acts as an Adjuvant to ChemotherapyLeslee Sprague, Joel M Lee, Brian J Hutzen, et al.
Cancer Research|June 3, 2006
Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase AJeffrey A Toretsky, Verda Erkizan, Amy Levenson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2008
Efficacy and safety of the oncolytic herpes simplex virus rRp450 alone and combined with cyclophosphamideMark A Currier, Rebecca A Gillespie, Nancy M Sawtell, et al.
Pediatric Blood & Cancer|October 14, 2014
Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children's Oncology GroupMichael J Burke, Charlotte Ahern, Brenda J Weigel, et al.
Cancer Research|August 25, 2012
In vivo regulation of TGF-β by R-Ras2 revealed through loss of the RasGAP protein NF1Deanna M Patmore, Sara Welch, Patricia C Fulkerson, et al.
Frontiers in Immunology|June 19, 2024
Enhanced IL-12 transgene expression improves oncolytic viroimmunotherapyYeaseul Kim, Uksha Saini, Doyeon Kim, et al.
Pageof 13